Synergistic action of tiazofurin and genistein in human ovarian carcinoma cells

Oncology Research

Volumn 10, Issue 3, 1998, Pages 117-122

  Li, Wei ^a   Weber, George ^a  

^a INDIANA UNIVERSITY   (United States)

Author keywords

Cell cycle; Genistein; Human ovarian carcinoma OVCAR 5 cells; Tiazofurin

Indexed keywords

ANTINEOPLASTIC AGENT; DRUG DERIVATIVE; GENISTEIN; GROWTH INHIBITOR; RIBAVIRIN; TIAZOFURIN;

ARTICLE; CARCINOMA; CELL CULTURE; DRUG POTENTIATION; DRUG SCREENING; FEMALE; HUMAN; METABOLISM; OVARY TUMOR;

ANTINEOPLASTIC AGENTS; CARCINOMA; DRUG SCREENING ASSAYS, ANTITUMOR; DRUG SYNERGISM; FEMALE; GENISTEIN; GROWTH INHIBITORS; HUMANS; OVARIAN NEOPLASMS; RIBAVIRIN; TUMOR CELLS, CULTURED;

EID: 0031616246     PISSN: 09650407     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Weber, G. Biochemical strategy of cancer cells and the design of chemotherapy: G.H.A. Clowes Memorial Lecture. Cancer Res. 43: 3466-3492; 1983.
2. Weber, G.; Prajda, N.; Abonyi, M.; Look, K. Y.; Tricot, G. Tiazofurin: Molecular and clinical action. Anticancer Res. 16: 3313-3322; 1996.
3. Olah, E.; Natsumeda, Y.; Ikegami, T.; Kote, Z.; Horanyi, M.; Szelenyi, J.; Paulik, E.; Kremmer, T.; Hollan, S. R.; Sugar, J.; Weber, G. Induction of erythroid differentiation and modulation of gene expression by tiazofurin in K562 leukemia cells. Proc. Natl. Acad. Sci. USA 85: 6533-6537; 1988.
4. Olah, E.; Kote, Z.; Natsumeda, Y.; Yamaji, Y.; Jarai, G.; Lapis, E.; Financsek, I.; Weber, G. Down-regulation of c-myc and c-Ha-ras gene expression by tiazofurin in rat hepatoma cells. Cancer Biochem. Biophys. 11: 107-117; 1990.
5. Weber, G.; Nagai, M.; Natsumeda, Y.; Eble, J. N.; Jayaram, H. N.; Paulik, E.; Zhen, W.; Hoffman, R.; Tricot, G. Tiazofurin down-regulates expression of c-Ki-ras oncogene in a leukemic patient. Cancer Commun. 3: 61-66; 1991.
6. Jayaram, H. N.; Dion, R. L.; Glazer, R. I.; Johns, D. G.; Robins, R. K.; Srivastava, P. C.; Cooney, D. A. Initial studies on the mechanism of action of a new oncolytic thiazole nucleoside, 2-β-D-ribofuranosylthiazole-4-carboxamide (NSC 286193). Biochem. Pharmacol. 31: 2371-2380; 1982.
7. Weber, G.; Shen, R; Prajda, N.; Yeh, Y. A.; Yang, H.; Herenyiova, M.; Look, K. Y. Increased signal transduction activity and down-regulation in human cancer cells. Anticancer Res. 16: 3271-3282; 1996.
8. Singhal, R. L.; Yeh, Y. A.; Look, K. Y.; Sledge, G. W., Jr.; Weber, G. Coordinated increase in activities of the signal transduction enzymes PI kinase and PIP kinase in human cancer cells. Life Sci. 55: 1487-1492; 1994.
9. 2+ mobilization in human platelets by affecting polyphosphoinositide turnover. Biochem. Pharmacol. 46: 395-403; 1993.
10. Weber, G.; Shen, F.; Prajda, N.; Yang, H.; Li, W.; Csokay, B.; Olah E.; Look, K. Y. Regulation of the signal transduction program by drugs. Adv. Enzyme Regul. 37: 35-55; 1997.
11. Akiyama, T.; Ishida, J.; Nakagawa, S.; Ogawara, H.; Watanabe, S.; Itoh, N.; Shibuya, M.; Fukami, Y. Genistein, a specific inhibitor of tyrosine-specific protein kinases. J. Biol. Chem. 262: 5592-5595; 1987.
12. Markovits, J.; Linassier, C.; Fosse, P.; Couprie, J.; Pierre, J.; Jacquemin-Sablon, A.; Saucier, J.-M.; Le Pecq, J.-B.; Larsen, A. K. Inhibitory effects of the tyrosine kinase inhibitor genistein on mammalian DNA topoisomerase II. Cancer Res. 49: 5111-5117; 1989.
13. Yamashita, Y.; Kawada, S.-Z.; Nakano, H. Induction of mammalian topoisomerase II dependent DNA cleavage by nonintercalative flavonoids, genistein and orobol. Biochem. Pharmacol. 39: 737-744; 1990.
14. Rauth, S.; Kichina, J.; Green, A. Inhibition of growth and induction of differentiation of metastatic melanoma cells in vitro by genistein: Chemosensitivity is regulated by cellular p53. Br. J. Cancer 75: 1559-1566; 1997.
15. 2-M. Cancer Res. 53: 1328-1331; 1993.
16. Yang, Y.; Yoo, H. M.; Choi, L; Pyun, K. H.; Byun, S. M.; Ha, H. Interleukin 4-induced proliferation in normal human keratinocytes is associated with c-myc gene expression and inhibited by genistein. J. Invest. Dermatol. 107: 367-372; 1996.
17. 1/S phase transition in BALB/c3T3 fibroblasts. Biochim. Biophys. Acta 1310: 185-192; 1996.
18. Pagliacci, M. C.; Spinozzi, F.; Migliorati, G.; Fumi, G.; Smacchia, M.; Grignani, F.; Riccardi, C.; Nicoletti, I. Genistein inhibits tumor cell growth in vitro but enhances mitochondrial reduction of tetrazolium salts: A further pitfall in the use of the MTT assay for evaluating cell growth and survival. Eur. J. Cancer 29: 1573-1577; 1993.
19. Pagliacci, M. C.; Smacchia, M.; Migliorati, G.; Grignani, F.; Riccardi, C.; Nicoletti, I. Growth-inhibitory effects of the natural phytooestrogen genistein in MCF-7 human breast cancer cells. Eur. J. Cancer 30: 1675-1682; 1994.
20. Hunakova, D.; Sedlak, J.; Klobusicka, M.; Duraj, J.; Chorvath, B. Tyrosine kinase inhibitor-induced differentiation of K-562 cells: Alterations of cell cycle and cell surface phenotype. Cancer Lett. 81: 81-87; 1994.
21. Spinozzi, F.; Pagliacci, M. C.; Migliorati, G.; Moraca, R.; Grignani, F.; Riccardi, C.; Nicoletti, I. The natural tyrosine kinase inhibitor genistein produces cell cycle arrest and apoptosis in Jurkat-T-leukemia cells. Leukemia Res. 18: 431-439; 1994.
22. Prajda, N.; Singhal, R. L.; Yeh, Y. A.; Olah, E.; Look, K. Y.; Weber, G. Linkage of reduction in 1-phosphatidylinositol 4-kinase activity and inositol 1,4,5-trisphosphate concentration in human ovarian carcinoma cells treated with quercetin. Life Sci. 56: 1587-1593; 1995.
23. Costantinou, A.; Kiguchi, K.; Huberman, E. Induction of differentiation and DNA strand breakage in human HL-60 and K-562 leukemia cells by genistein. Cancer Res. 50: 2618-2624; 1990.
24. Weber, G.; Nagai, M.; Prajda, N.; Nakamura, H.; Szekeres, T.; Olah, E. AZT: A biochemical response modifier of methotrexate and 5-fluorouracil cytotoxicity in human ovarian and pancreatic carcinoma cells. Cancer Commun. 3: 127-132; 1991.
25. Chou, T.-C.; Talalay, P. Quantitative analysis of dose-effect relationships: The combined effects of multiple drugs or enzyme inhibitors. Adv. Enzyme Regul. 22: 27-55; 1984.
26. Berenbaum, M. C. Criteria for analyzing interactions between biologically active agents. Adv. Cancer Res. 35: 269-335; 1981.
27. Adlercreutz, H.; Markkanen, H.; Watanabe, S. Plasma concentrations of phyto-oestrogens in Japanese men. Lancet 342: 1209-1210; 1993.
28. Olah, E.; Csokay, B.; Prajda, N.; Kote-Jarai, Z.; Yeh, Y. A.; Weber, G. Molecular mechanisms in the antiproliferative action of taxol and tiazofurin. Anticancer Res. 16: 1-9; 1996.
29. Weber, G.; Singhal, R. L.; Prajda, N.; Yeh, Y. A.; Look, K. Y.; Sledge, G. W., Jr. Regulation of signal transduction. Adv. Enzyme Regul. 35: 1-21; 1995.
30. Shen F.; Weber, G. Synergistic action of quercetin and genistein in human ovarian carcinoma cells. Oncol. Res. 9: 597-602; 1997.
31. Tricot, G. J.; Jayaram, H. N.; Lapis, E.; Natsumeda, Y.; Yamada, Y.; Nichols, C. R.; Kneebone, P.; Heerema, N.; Weber, G.; Hoffman, R. Biochemically directed therapy of leukemia with tiazofurin, a selective blocker of inosine 5′-phosphate dehydrogenase activity. Cancer Res. 49: 3696-3701; 1989.
32. Tricot, G.; Jayaram, H. N.; Weber, G.; Hoffman, R. Tiazofurin: Biological effects and clinical uses. Int. J. Cell Cloning 8: 161-170; 1990.